EPISODE · Sep 21, 2025 · 31 MIN
268. Revolutionizing Breast Cancer Detection with JP Parthasarathy founder and CEO of Astrin Biosciences
from Breast Cancer Conversations · host SurvivingBreastCancer.org
Love the podcast? Send us a text!In this conversation, Laura Carfang interviews JP Parthasarathy, the founder and CEO of Astran Biosciences, about the critical topic of breast cancer, particularly focusing on breast density and its implications for women's health. They discuss the importance of understanding breast density, the advancements in early cancer detection technologies, and the ongoing clinical trials aimed at improving screening methods. JP shares insights into the science behind cancer progression, the risk factors associated with breast density, and the potential for blood tests to revolutionize cancer screening. The conversation emphasizes the need for personalized medicine and the importance of empowering patients with knowledge about their health risks.What you will learn: Breast density is a significant risk factor for breast cancer.Many women are unaware of their breast density and its implications.Early detection of cancer cells is crucial for effective treatment.Current mammogram technologies may not effectively detect cancers in dense breasts.Personalized screening programs can improve outcomes for high-risk individuals.The science of cancer progression is evolving, revealing new insights.Blood tests may provide a less invasive method for early cancer detection.Advocacy and awareness are key in improving women's health outcomes.Understanding individual risk factors can lead to better screening strategies.The future of cancer detection lies in integrating advanced technologies and personalized medicine.Attend a free virtual SurvivingBreastCancer.org program (support groups, yoga, medication, expressive writing, art expression, and more!):https://www.survivingbreastcancer.org/eventsSubscribe to our weekly newsletterhttps://www.survivingbreastcancer.org/subscribeFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/Support our Podcast, every dollar counts! https://givebutter.com/0fCiEUSupport the showListener FeedbackIf this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.Messages are completely anonymous.If you would like us to follow up directly, please include your email address in your message so we can respond.Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Become a Breast Cancer Conversations+ Member! Sign Up Now. Enjoying our content? Please consider supporting our work.
What this episode covers
Love the podcast? Send us a text! In this conversation, Laura Carfang interviews JP Parthasarathy, the founder and CEO of Astran Biosciences, about the critical topic of breast cancer, particularly focusing on breast density and its implications for women's health. They discuss the importance of understanding breast density, the advancements in early cancer detection technologies, and the ongoing clinical trials aimed at improving screening methods. JP shares insights into the science behind ...
NOW PLAYING
268. Revolutionizing Breast Cancer Detection with JP Parthasarathy founder and CEO of Astrin Biosciences
No transcript for this episode yet